Using the broad-host-range plasmid vector pRO1614, we cloned a segment of the gene from Pseudomonas aeruginosa PA103 encoding the enzymatically active part of the exotoxin A protein. Expression of the cloned gene segment has been achieved both in Escherichia coli and in a nontoxigenic P. aeruginosa host, as assayed by the production of exotoxin A-related antigen and by the ability of the gene product to ADP-ribosylate elongation factor 2. Western blot hybridization analysis revealed a series of polypeptides antigenically related to exotoxin A, the largest of which had a molecular weight of ca. 50,000.
Pseiudomonas aeriuginosa exotoxin A, a protein of ca. 68,000 molecular weight secreted by many strains of P. aerluginosa (2, 28) , may be a virulence factor of this species (9, 19, 36) , which in recent years has emerged as one of the most common organisms acquired by hospital infection. The mode of action of exotoxin A closely parallels that of diphtheria toxin (26) , causing' the arrest of protein synthesis within the cytoplasm of mammalian cells by catalyzing the covalent attachment of the ADP-ribosyl moiety of NAD+ to elongation factor 2 (EF-2), thus inactivating EF-2 and killing the cell (14, 35) . Other aspects of the mechanism of exotoxin A action are less well understoood, specifically, how that part of exotoxin A comprisinig the active site is transported through a membrane barrier into the cell cytoplasm.
There is also a broader interest in understanding the cytocidal mechanisms of protein toxins such as exotoxin A, because they can be used to construct hybrid toxins that may have clinical applications. Hybrid toxins are prepared by attaching a natural toxin, or part of a natural toxin, to a component that binds to a specific cell surface receptor (for example, a monoclonal antibody), thereby directing the toxin to attack only those cells bearing the chosen receptor (25) . We report here the cloning of a segment of P. aeeruiginosa chromosomal DNA encoding a part of exotoxin A that contains the enzymatically active site. The availability of the gene for exotoxin A should facilitate the production of structural variants of the protein that will be useful in structural-functional studies of exotoxin A action and in constructing new hybrid toxins.
MATERIALS AND METHODS Bacterial strains and plasmids. HB101 is a hsdS20 recA/3 ara-14 proA2 lac YI galK2 rpsL20 xyl-5 intl-l sitpE44 A-FEscherichia coli K-12 strain without restriction activity (3) . PA103 is a prototrophic, high-exotoxin-A-producing strain of P. aeruginosa (18) . Several derivatives of PAO1, another wild-type toxigenic P. aeriuginosa strain, were also used: PA0286, a met-28 trp-6 mutant (32); PA0949, a thr-9001 cys-59 piur-67 mutant (29) ; and GMA253, a cys-5605 his15075 mutant (22, 31) . The broad-host-range vector plasmid pRO1614, able to replicate in either P. aeriuginosa or E. coli, is described by Olsen et al. (24) ; pRO1614 is a pBR322 plasmid with an approximate 1.85-kilobase-pair (kbp) segment inferred to be the replication control segment of RP1 inserted into the PstI site. It thus carries the carbenicillin and * Corresponding author.
tetracycline resistance determinants and cloning sites of pBR322, including the unique BamHI cleavage site within the tetracycline resistance (tet) gene. The chromosomemobilizing R-plasmid R68.45 used in mapping studies of Pseudomonas sp. has been described previously (10, 11 (15) , deferrated with CaCI, and supplemented with 0.1 M monosodium glutamate and 1% glycerol. Solid TSBD was prepared by adding agarose (SeaKem) to 1.2%. Minimal glucose medium has been previously described (13) and was supplemented with amino acids and nucleotides, each to a concentration of 20 ,ug/ml. Where appropriate, disodium carbenicillin was added to a concentration of 300 ,ug/ml.
Isolation and mapping of the Tox-mutant MAM2. An exotoxin A-deficient (Tox-) mutant of P. aeruiginosa was isolated after mutagenesis of strain PA0286 with nitrosoguanidine (1). This mutant, MAM2, was initially identified because it did not produce material that cross-reacted with anti-exotoxin A antibodies (CRM-phenotype) as assayed by the Elek test (2) , an immunodiffusion assay for secreted bacterial proteins. The mutation in MAM2 responsible for the CRM-phenotype was mapped as described by Haas and Holloway (10, 11) [35] ) was added to a concentration of 100 pg/ml, and incubation was continued at room temperature with gentle agitation for ca. 18 h. The filters were then washed extensively in six changes of TBS containing 0.1% sodium dodecyl sulfate (SDS) in the first wash and then again preincubated in BSA-TBS as described above. Staphylococcus aiureius protein A (Sigma), labeled with 125I by using lodo-beads (Pierce) as described by Markwell (21) , was then added to a concentration of 106 cpm/ml (specific activity = 9 x 106 cpm/,ug), and the filters were incubated at room temperature with gentle agitation for 1 to 4 h. The filters were then washed as described above, and autoradiography was performed.
For verification of original isolates as antigen positive, areas from the replica filters carrying the putative clones were excised, and the bacteria were suspended in 0.85% NaCl. The bacterial suspensions were streaked onto nutrient agar plates containing carbenicillin and incubated overnight at 30°C. Bacteria from single colonies were then inoculated to nitrocellulose filters on supplemented TSBD plates with carbenicillin, incubated overnight at 30°C, and tested for exotoxin A-related antigen by the method described above.
Western blot hybridization analysis. Exotoxin A-related polypeptides expressed by antigen-positive transformants were examined by Western blot analysis (5). Cultures (50 ml) were grown to a density of ca. 5 x 108 cells per ml in supplemented TSBD medium plus 300 pug of carbenicillin per ml. Bacteria were pelleted by centrifugation at 4°C and suspended in 2 ml of ice-cold 50 (Fig. 1, rows A and B) and analyzed in detail. The recombinant piasmid found in clone 56C1 has been designated pRC345.
Digestion of pRC345 with BamHI produced nine fragments ranging in size from 0.16 to 6.4 kbp (data not shown). The order of the fragments ( Fig. 2A) MAM2 carrying pRO1614 showed no immunologically reactive proteins in the Western blot hybridization analysis, whereas MAM2 carrying pRC345 produced a collection of exotoxin A-related polypeptides similar to that seen in HB101 (pRC345) (Fig. 3) . Presumably, the primary translation product is recognized as an abnormal protein in both E. coli and P. aeruginosa and is subject to proteolytic attack in both hosts.
The exotoxin A-related protein encoded by pRC345 possessed enzymatic activity, even though the protein expressed from the clone was not full-size exotoxin A and was apparently subject to proteolysis. Table 1 shows results of an assay for the EF-2 ADP-ribosylating activity of cytoplasmic fractions from E. coli or P. aeruginosa host cells carrying pRC345. Cytoplasmic fractions, rather than culture supernatants, were assayed for enzymatic activity since neither HB101(pRC345) nor MAM2(pRC345) appeared to secrete exotoxin A-related antigen as assayed by the Elek test (data Fig. 2B .
The catalytic site of exotoxin A has been shown to reside on polypeptides of 26,000 to 27,000 molecular weight that can be recovered from stored preparations (7, 35) or from chymotrypsin cleavage (20) of whole toxin. Also, a 48,000-molecular-weight polypeptide derived from digestion of whole toxin by P. aeriuginosa elastase is enzymatically active (30 Fig. 2 , since pRO1614 carrying only the 0.22-kbp BamHI-Sau3A fragment did not produce material that cross-reacted with anti-exotoxin A antibodies (data not shown). Thus, it seems likely that pRC345 carries the C terminus of the toxA structural gene at the left-hand vector-insert junction. In this event, we believe transcription is initiated from the P2 tetracycline resistance (tet) gene (4) promoter of pBR322 located on the 0.37-kbp EcoRI-BamHI fragment, which results in transcription toward the BamHI site (i.e., clockwise towards the insert DNA). Translation would thus be initiated at the start codon that begins at the nucleotide located 86 base pairs (clockwise) from the EcoRI site (27) . If the exotoxin gene sequence is in the same reading frame, as appears to be the case, this would produce a hybrid polypeptide with 96 amino acids of the N-terminal region of the tet protein linked to a polypeptide carrying the antigenic and enzymatic activity of exotoxin A. Such a postulated hybrid polypeptide would include ca. 11,000 molecular weight of the tet protein (27) ; the remaining approximate 39,000 molecular weight would presumably derive from toxA structural gene sequences present primarily, or exclusively, on the 0.52-kbp BamHI and 0.45-kbp BamHI-EcoRI restriction fragments of pRC345. The absence of the N-terminal part of exotoxin A in a hybrid protein of this type also explains why the product is not secreted.
As stated above, subclone 8E4 produced a polypeptide of ca. 35,000 molecular weight that was immunologically related to exotoxin A. The order of the BamHI restriction fragments at the left vector-insert junction is not the same in pRC346 as in pRC345, presumably due to cleavage and religation during the subcloning process (Fig. 2) . This suggests that the 0.47-and 0.16-kbp BamHI fragments are not part of the toxA coding sequence, but may provide a translation initiation codon that resulted in expression of a new hybrid polypeptide containing the toxA sequences present on the 0.45-kbp C-terminal BamHI-EcoRI fragment. The fact that the exotoxin A-related polypeptide expressed from pRC346 does not possess EF-2 ADP-ribosylating activity may result from the absehce of the 0.52-kbp BamHl fragment in this subclone, or may be related to differences in protein conformation between the pRC345-and pRC346-encoded polypeptides.
We are presently screening new clones which we anticipate will contain the intact toxA structural gene. Such clones will be useful in site-directed mutagenesis experiments aimed at elucidating structural-functional relationships of exotoxin A and in the construction of hybrid toxins. 
